Beta Drugs Ltd.
| BSE: 535022 | Sector: Health care |
| NSE: BETA | ISIN Code: INE351Y01019 |
| BSE 05:30 | 01 Jan | Beta Drugs Ltd |
| NSE 15:40 | 25 May | 880.90 |
-4.25 (-0.48%) |
OPEN
885.10 |
HIGH
894.00 |
LOW
850.10 |
| OPEN | |
| PREVIOUS CLOSE | |
| VOLUME | |
| 52-Week high | 0.00 |
| 52-Week low | 0.00 |
| P/E | |
| Mkt Cap.(Rs cr) | 0 |
| Buy Price | |
| Buy Qty | |
| Sell Price | |
| Sell Qty |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Beta Drugs Ltd. (BETA) - Cash Flow
| Figures in Rs crore | 2021 | 2020 | 2019 |
| Opening Cash & Cash Equivalents | 4.16 | 2.92 | 11.91 |
| Net Cash From Operating Activities | 11.60 | 6.09 | 7.73 |
| Net Cash Used In/from Investing Activities | -3.15 | -14.33 | -16.08 |
| Net Cash Used In/from Financing Activities | -4.34 | 9.48 | -0.64 |
| Net (decrease)/increase In Cash and Cash Equivalents |
4.10 | 1.24 | -8.99 |
| Closing Cash & Cash Equivalents | 8.27 | 4.16 | 2.92 |
Quick Links for Beta Drugs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
